Systematic analysis of the biological roles and pharmacological properties of D-chiro-inositol
D-chiroinositol (DCI) is one of the 9 inositol isomers that forms inositol phosphoglycans, which are mediators of the action of insulin. The metabolism of DCI and myo-inositol (MI) is impaired against the background of insulin resistance, including the patients with polycystic ovary syndrome (PCOS)....
Saved in:
Main Authors: | Olga A. Gromova (Author), Ivan Yu. Torshin (Author), Elena V. Uvarova (Author), Natalya I. Tapilskaya (Author), Alla G. Kalacheva (Author) |
---|---|
Format: | Book |
Published: |
IP Berlin A.V.,
2020-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Does ovary need D-chiro-inositol?
by: Isabella Rosalbino, et al.
Published: (2012) -
Metabolic Effects of D-Chiro-Inositol and Myo-Inositol in Polycystic Ovary Syndrome
by: Rim Hanna, et al.
Published: (2017) -
Efficiency of the D-chiro-inositol for the polycystic ovary syndrome
by: Т. Л. Архипкина, et al.
Published: (2019) -
Update on the combination of myo-inositol/d-chiro-inositol for the treatment of polycystic ovary syndrome
by: Iñaki Lete, et al.
Published: (2024) -
Expression of Concern to: Does ovary need D-chiro-inositol?
by: Rosalbino Isabella, et al.
Published: (2018)